Biotech

Founded in 1987, Canaan is a long-established early-stage investor, currently investing from their 12th fund ($800M).

Founded by Nish Bhat, Carbon Silicon Ventures backs founders applying engineering and scalability to biology and healthcare innovations.

Globally invests, with offices in California, Israel, India, and China.

Climate Capital is a climate tech VC with over 250 portfolio companies, working to decarbonize the economy. They use a collaborative Slack community and provide knowledge-sharing resources.

Focuses on innovative solutions in health tech and biology to transform healthcare and its impact.

Invests in companies focused on sustainable consumer products, advanced recycling technologies, and promoting a circular economy.

Invests in startups born from science projects, applying a thesis-driven approach to realize their full commercial potential.

Correlation Ventures uses world-class analytics to provide venture funding quickly and efficiently, offering decisions in two weeks or less with a flexible approach that does not require board seats. They do not invest in certain sectors such as tobacco, firearms, or real property.

Focuses on companies addressing critical issues such as labor shortages, spiraling healthcare costs, and sustainable food production, helping create sustainable and scalable solutions.

Uses a hybrid approach, investing in both funds and promising startups at the Seed and Series A stages, supported by diverse investors, including family offices, institutions, and notable individuals.

With a history of early-stage investments since 1970, this firm backs technology startups with conviction through all stages of growth.

Supports entrepreneurs leveraging Deep Tech to address challenges, amplifying the positive impact of capitalism while cutting its costs.

With over 25 years of history, Delphi Ventures was among the pioneers in venture capital for life sciences companies.

Funds initiatives that provide solutions to intricate issues in human and animal health.

An unprecedented fund partnering with founders at the intersection of technology and life sciences to reshape the future of life on earth, currently investing via Dimension 1, a $350M fund targeting incubation through growth in drug discovery platforms, machine learning, tools, services, and life sciences digitization software companies.

Founded by actor Will Smith and soccer star Keisuke Honda to connect Japanese corporate investors with early-stage U.S. companies, Dreamers invests in innovative ventures to improve lives through emerging technologies.

Concentrates on pre-seed deep tech startups developing unique intellectual property.

Elevate is a group of seasoned operators funding and assisting promising Indiana startups in their earliest stages.

Invests in healthcare and technology ventures in the U.S. and Europe, established in 1946, managing over $2T in assets.

Believes that iconic companies know no boundaries; they can be created anywhere, by anyone, whether curing rare diseases or enabling global payments. Partners with founders globally, across sectors, and at various stages, often before success becomes evident.

Supporting tech-driven entrepreneurs tackling the world's most pressing challenges.

First In Ventures, located in Middletown, Delaware, invests in early-stage biotech and life sciences startups.

Collaborates with entrepreneurs tackling real-world challenges via data and machine learning, focusing on AI, computational biotech, connected sensors, AR/VR, and blockchain applications.

A $150M tech-focused venture fund in Los Altos, California, investing in early-stage startups across software, life sciences, and deep tech.

San Francisco-based Founders Fund invests in science and tech companies tackling challenging problems. They invest at all stages, following a founder-friendly strategy that emphasizes support with minimal interference.

Focuses on long-term, concentrated investments in founders who grow with their companies, maximizing impact over decades, without limiting by sector, geography, or stage.

Launched as Google Ventures in 2009, GV operates as an independent VC firm backed by Alphabet, focusing on supporting founders at the earliest stages of company-building.

HTH is an investment and advisory firm investing in health-focused innovators since 2016. They work closely with pharma companies to fund life science ventures, provide corporate innovation capabilities, and open stakeholder networks. Their science-first approach involves deep due diligence, including data, models, and clinical expert interviews, typically completed within 1-2 months.

Founded by Dr. Ling Wong, this firm funds companies using science and technology to create a better future.

Funds early-stage companies blending engineering with physical and life sciences to create technologies that solve pressing global challenges.